Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours J Simon, LG Perez-Rivas, Y Zhao, F Chasseloup, H Lasolle, C Cortet, ... European journal of endocrinology 189 (3), 372-378, 2023 | 7 | 2023 |
Aggressive pituitary tumors and pituitary carcinomas: from pathology to treatment P Burman, O Casar-Borota, LG Perez-Rivas, OM Dekkers The Journal of Clinical Endocrinology & Metabolism 108 (7), 1585-1601, 2023 | 19 | 2023 |
Intact GR dimerization is critical for restraining plasma ACTH levels during chronic psychosocial stress D Langgartner, M Koenen, S Kupfer, L Glogger, L Kurz, LG Perez-Rivas, ... Neurobiology of Stress 24, 100541, 2023 | 1 | 2023 |
TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome LG Perez-Rivas, J Simon, A Albani, S Tang, S Roeber, G Assié, ... Acta Neuropathologica Communications 10 (1), 139, 2022 | 16 | 2022 |
Improved pasireotide response in USP8 mutant corticotroph tumours in vitro A Albani, LG Perez-Rivas, S Tang, J Simon, KE Lucia, P Colón-Bolea, ... Endocrine-Related Cancer 29 (8), 503-511, 2022 | 15 | 2022 |
TP53 mutations in functional corticotroph tumours: prevalence and clinical relevance LG Perez-Rivas, J Simon, A Albani, R Rotermund, PR Hermus, ... Endocrine Abstracts 73, 2021 | | 2021 |
Expression and putative role of 14–3-3 proteins in corticotroph tumours S Tang, LG Perez-Rivas, A Albani, R Rotermund, J Flitsch, J Honegger, ... Endocrine Abstracts 73, 2021 | | 2021 |
HIF1α is a direct regulator of steroidogenesis in the adrenal gland D Watts, J Stein, A Meneses, N Bechmann, A Neuwirth, D Kaden, ... Cellular and Molecular Life Sciences 78, 3577-3590, 2021 | 20 | 2021 |
Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations M Reincke, A Albani, G Assie, I Bancos, T Brue, M Buchfelder, O Chabre, ... European journal of endocrinology 184 (3), P1-P16, 2021 | 42 | 2021 |
Diagnosis and treatment of parasellar lesions F Gatto, LG Perez-Rivas, NC Olarescu, P Khandeva, K Chachlaki, ... Neuroendocrinology 110 (9-10), 728-739, 2020 | 31 | 2020 |
Evidence for increased SSTR5 expression and improved pasireotide response in USP8 mutant corticotroph tumours A Albani, LG Perez-Rivas, T Sicheng, M Buchfelder, R Rotermund, ... Endocrine Abstracts 70, 2020 | 2 | 2020 |
Driver mutations in USP8 wild-type Cushing’s disease S Sbiera, LG Perez-Rivas, L Taranets, I Weigand, J Flitsch, E Graf, ... Neuro-oncology 21 (10), 1273-1283, 2019 | 87 | 2019 |
Aggressive and malignant prolactinomas NC Olarescu, LG Perez-Rivas, F Gatto, T Cuny, MA Tichomirowa, ... Neuroendocrinology 109 (1), 57-69, 2019 | 32 | 2019 |
Heat shock protein 90 as a prognostic marker and therapeutic target for adrenocortical carcinoma C Siebert, D Ciato, M Murakami, L Frei-Stuber, LG Perez-Rivas, ... Frontiers in endocrinology 10, 487, 2019 | 18 | 2019 |
Correlation between responsiveness to CRH stimulation test in Cushing A Albani, L Perez-Rivas, M Buchfelder, J Honegger, G Stalla, S Zopp, ... Endocrine Abstracts 63, 2019 | | 2019 |
Ubiquitin-specific protease 8 (USP8) potentiates glucocorticoid receptor activity in corticotroph tumour cells L Perez-Rivas, D Ciato, P Colon-Bolea, M Reincke, M Theodoropoulou Endocrine Abstracts 63, 2019 | | 2019 |
Inherited forms of primary hyperaldosteronism: new genes, new phenotypes and proposition of a new classification LG Perez-Rivas, TA Williams, M Reincke Experimental and Clinical Endocrinology & Diabetes 127 (02/03), 93-99, 2019 | 31 | 2019 |
Pathogenesis of cushing disease: an update on the genetics of corticotropinomas A Albani, LG Perez-Rivas, M Reincke, M Theodoropoulou Endocrine Practice 24 (10), 907-914, 2018 | 22 | 2018 |
The USP8 mutational status may predict long‐term remission in patients with Cushing's disease A Albani, LG Pérez‐Rivas, C Dimopoulou, S Zopp, P Colón‐Bolea, ... Clinical endocrinology 89 (4), 454-458, 2018 | 79 | 2018 |
Microrna signature as an indicator of the risk of early recurrence in patients with breast cancer JL CASTRO, EA CONEJO, LGP Rivas, JJ ARAGONÉS, NR ENTRENA US Patent 10,059,998, 2018 | 1 | 2018 |